Tuesday, April 01, 2014 6:05:03 PM
"The ASCO Late-Breaking Abstracts Policy allows for the submission of Late-Breaking Abstracts only for randomized phase II and phase III trials for which no preliminary data are available at the time of the abstract submission deadline (February 4, 2014), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 1, 2014 (deadline for the final, updated Late-Breaking Abstract)."
Please correct if I am wrong, but ONCS trials would not qualify for this as they are not randomized.
Unless there is an exception to this rule, ONCS would already be notified and thus we should hope they are simply waiting to announce this later, possibly as the rep mentioned on or after April 21.
Thoughts????
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM